openPR Logo
Press release

Paediatric Vaccine Market Key Players : GlaxoSmithCline, Merck, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly and Company, Pfizer, F

11-16-2018 10:39 AM CET | Health & Medicine

Press release from: Allied Market Research

Paediatric Vaccine Market

Paediatric Vaccine Market

Vaccine provides protection against particular diseases by improving immunity. Vaccines are the biological preparations of weakened or killed microorganism, its surface proteins or its toxins. The global paediatric vaccine market is expected to witness a strong growth during the forecast period due to launch of new products in the market. In-depth discussion of global paediatric vaccine market includes past and current trends with future forecast through 2020. Detailed study of market drivers, threats and opportunities would assist corporate professionals in their strategic decisions. The report also proffers detailed geographical segmentation and identifies profitable areas.

Competitive Landscape

The leading companies in the global paediatric vaccine market include GlaxoSmithCline, Merck, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly and Company, Pfizer, F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, and others. GlaxoSmithCline leads the global vaccine market followed by Sanofi and Pfizer. Prevnar-13 (Pneumococcal vaccine), by Pfizer is the top selling brand amongst the other vaccine products.

Get Sample PDF Brochure : https://www.alliedmarketresearch.com/request-toc-and-sample/438

High Level Analysis

The study identifies the potential market drivers, challenges and trends. Competitive landscape section provides explicit information of the top players ruling the global paediatric vaccine market, their operating strategies, new launches, pipeline therapies and clinical trials. Porter’s Five Forces analysis has been used to determine the attractiveness of global paediatric vaccine market. Few top players such as GlaxoSmithCline, Merck, Sanofi, Pfizer and Novartis contribute to more than 70% of total vaccine market. This factor strengthens the suppliers’ power. Threat of substitute product is less due to emergence of vaccine as therapeutic agents. Industrial rivalry is intense due to exhaustive R&D activities and clinical trials to innovate new vaccine products and vaccine delivery technology.

The global paediatric vaccine market is expected to grow at a healthy CAGR in next few years. Increase in growth would be primarily attributed to improved understanding of immunology, which has resulted in launch of new vaccines products. Technological breakthrough has led to development of new vaccine class such as DNA vaccines, vector vaccines, intranasal vaccines, mucosal vaccines and others. However, manufacturing complexity and stringent regulatory compliance are the factors that hinder the market growth. Refusal to immunization and vaccines shortages are other restraints for this market. Emergence of vaccines as therapeutic agents has added new dimension to vaccine industry and it could be the answer to most of the chronic diseases including cancer. Alliances, partnerships and collaborations by big players to expand the business could also boost the market growth.

Global Paediatric Vaccine Market by Type

The global paediatric vaccine market is segmented by type of vaccines into different categories such as Pneumococcal, Varicella, Combinations, Poliovirus, Hepatitis, MMR, Paediatric Hormones, HIB, Allergy and Respiratory vaccines and Other Pediatric vaccines. Pneumococcal vaccines dominate the segment followed by HIB and other combination products.

Global Paediatric Vaccine Market by Geography

Geographically, global paediatric vaccine market is segmented into North America, Europe, Asia-pacific and LAMEA. North America and Europe leads the global paediatric vaccine market due to the purchasing power of costly vaccines by the consumers and favorable reimbursement policies. Asia-Pacific is the emerging market for paediatric vaccines due to rising GDP and growing demand for safe and efficacious therapeutics.

KEY BENEFITS

• This report offers the following benefits in particular:
• Comprehensive coverage of global paediatric vaccine market along with vaccine types, market trends, drivers and restraints would assist strategist in making strategic business decisions
• Thorough attention is given to leading company portfolios, pipeline research, new launches and competitive landscape of top players
• Explicit information on current clinical trials and R&D activities would be beneficial to gain a deeper understand of the future market trends
• Insightful analysis of different segments helps to recognize and capitalize future opportunities within global paediatric vaccine market

KEY DELIVERABLES

The global paediatric vaccine market is segmented into two major categories such as type and geography.

MARKET BY TYPE

• Pneumococcal
• Varicella
• Combinations
• Poliovirus
• Hepatitis
• MMR
• Pediatric Hormones
• HIB
• Allergy and Respiratory vaccines
• Other Pediatric vaccines

MARKET BY GEOGRAPHY

• North America
• Europe
• Asia-Pacific
• LAMEA

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Paediatric Vaccine Market Key Players : GlaxoSmithCline, Merck, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly and Company, Pfizer, F here

News-ID: 1376476 • Views:

More Releases from Allied Market Research

Pollution Absorbing Bricks Market Major Companies, Strategies and New Trends to Reach $9.7 Bn by 2032
Pollution Absorbing Bricks Market Major Companies, Strategies and New Trends to …
According to a new report published by Allied Market Research, titled, The Pollution Absorbing Bricks Market was valued at $5.3 billion in 2022, and is estimated to reach $9.7 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032. Pollution absorbing brick, also known as air purifying brick, is a cutting-edge building material used to curb air pollution. These bricks are manufactured using a specific coating or chemical
Satellite Ground Station Market To Grow From $58.7 Billion in 2022 to $178.9 Billion by 2032, Registering a CAGR of 11.9%
Satellite Ground Station Market To Grow From $58.7 Billion in 2022 to $178.9 Bil …
According to a new report published by Allied Market Research, titled, "Satellite Ground Station Market," The satellite ground station market size was valued at $58.70 billion in 2022, and is estimated to reach $178.9 billion by 2032, growing at a CAGR of 11.9% from 2023 to 2032. North America currently dominated the satellite ground station market in 2022. The presence of big satellite ground station providers namely EchoStar Corporation, Telesat, and
Cardiovascular Diagnostic Testing Market Expected to Reach $15.4 Billion by 2030 | Big Corps Trends and Strategy Analysis
Cardiovascular Diagnostic Testing Market Expected to Reach $15.4 Billion by 2030 …
Cardiovascular diagnostic market was valued at $6,876.29 million in 2020, and is projected to reach $15,430.46 million by 2030, registering a CAGR of 8.3% from 2021 to 2030. Cardiovascular diseases are a leading cause of mortality in humans, and millions of individuals worldwide die from acute cardiovascular events every year. Several Laboratory developed tests as well as in-vitro diagnostic tests are used for diagnostic and prognostic purposes. 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
Oral Cancer Treatment Market Drivers Shaping Future Growth, Revenue USD 2.7 billion by 2030 - AMR
Oral Cancer Treatment Market Drivers Shaping Future Growth, Revenue USD 2.7 bill …
Rise in prevalence of oral cancer and surge in government expenditure on healthcare drive the growth of the global oral cancer treatment market. However, adverse effects regarding usage of cancer drugs hinder the market growth. On the other hand, rise in number of pipeline drugs and untapped potential in emerging countries create new opportunities in the coming years. According to the report published by Allied Market Research, The global Oral Cancer

All 5 Releases


More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the